Literature DB >> 9052451

Transhiatal oesophagectomy for benign obstructive conditions of the oesophagus.

N M Gupta1, M K Goenka, A Behera, D K Bhasin.   

Abstract

BACKGROUND: Transhiatal oesophagectomy is an accepted approach for the treatment of carcinoma of the oesophagus. However, experience of this technique in benign diseases is limited.
METHODS: Transhiatal oesophagectomy was done in 29 patients for benign oesophageal conditions including corrosive stricture (21), achalasia of the cardia (four), tuberculosis (one), mediastinal fibrosis (one), Crohn's disease (one) and peptic stricture (one). Dysphagia was the predominant symptom in all patients; strictures had all previously been dilated repeatedly. The stomach was used as an oesophageal substitute in 24 patients; in five with a scarred stomach due to damage by a corrosive agent, oesophagocoloplasty was performed. Resection and reconstruction were done in one stage in 25 patients; four with poor nutritional status had a two-stage procedure.
RESULTS: There was no perioperative death. Complications encountered were recurrent laryngeal nerve palsy (six patients) which was mostly transient, anastomotic leak (seven) and stenosis (eight). Postoperative function of the intrathoracic stomach was satisfactory.
CONCLUSION: Transhiatal oesophagectomy is a safe and satisfactory procedure for benign obstructive conditions of the oesophagus.

Entities:  

Mesh:

Year:  1997        PMID: 9052451

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  2 in total

1.  Transhiatal esophageal resection for corrosive injury.

Authors:  Narendar Mohan Gupta; Rajesh Gupta
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

2.  Incidence and Risk Factors of an Intraoperative Arrhythmia in Transhiatal Esophagectomy.

Authors:  Mojtaba Ahmadinejad; Mozaffar Hashemi; Abbas Tabatabai; Shahram Keykha; Zabihollah Taleshi; Koorosh Ahmadi
Journal:  Iran Red Crescent Med J       Date:  2015-12-26       Impact factor: 0.611

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.